The World Health Organization said Thursday it recommends against the use of remdesivir, the antiviral drug for Covid-19 made by Gilead Sciences Inc., after concluding that there isn’t evidence that the drug reduces deaths or recovery times.
The WHO said a panel of international experts that advise the agency on treatments based its recommendation on data from four international clinical trials comparing the effects of several drug treatments.
Remdesivir…
This post first appeared on wsj.com
